Market Cap Chart

Historical Market Cap Data

View and export this data back to 2011. Start Trial.
Date Value
November 18, 2026 4.788M
November 17, 2026 4.908M
November 16, 2026 2.565M
November 13, 2026 2.565M
November 12, 2026 2.565M
November 11, 2026 3.736M
November 10, 2026 2.582M
November 09, 2026 2.582M
November 06, 2026 2.565M
November 05, 2026 2.565M
November 04, 2026 2.565M
November 03, 2026 3.591M
November 02, 2026 3.591M
October 30, 2026 3.078M
October 29, 2026 3.078M
October 28, 2026 3.95M
October 27, 2026 3.95M
October 26, 2026 4.104M
October 23, 2026 4.104M
October 22, 2026 4.104M
October 21, 2026 4.104M
October 20, 2026 4.104M
October 19, 2026 4.104M
October 16, 2026 3.95M
October 15, 2026 3.95M
Date Value
October 14, 2026 3.95M
October 13, 2026 3.95M
October 12, 2026 3.95M
October 09, 2026 3.95M
October 08, 2026 4.446M
October 07, 2026 4.446M
October 06, 2026 5.985M
October 05, 2026 4.001M
October 02, 2026 4.001M
October 01, 2026 4.001M
September 30, 2026 4.001M
September 29, 2026 4.001M
September 28, 2026 4.001M
September 25, 2026 4.001M
September 24, 2026 4.001M
September 23, 2026 3.933M
September 22, 2026 3.933M
September 21, 2026 6.489M
September 18, 2026 3.967M
September 17, 2026 3.967M
September 16, 2026 3.933M
September 15, 2026 3.933M
September 14, 2026 3.933M
September 11, 2026 3.933M
September 10, 2026 3.933M

Market Capitalization Definition

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.

Read full definition.

Market Cap Range, Past 5 Years

View Market Cap Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Market Cap Benchmarks

View Market Cap Benchmarks
Start Trial
Immutep Ltd. 23.95M
CSL Ltd. 63.02B
Propanc Biopharma, Inc. 1.731M
Mesoblast Ltd. 1.509B
Actinogen Medical Ltd. 1.090B

Market Cap Related Metrics

PE Ratio 0.0216
PS Ratio 6749.73
Price 0.028
Earnings Yield 4.64K%
Normalized PE Ratio 0.0889